New World Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,959
Closed -$234K 70
2021
Q4
$234K Sell
3,959
-2,800
-41% -$139K 0.11% 66
2021
Q3
$292K Sell
6,759
-14,386
-68% -$637K 0.13% 55
2021
Q2
$828K Buy
+21,145
New +$822K 0.56% 41
2019
Q2
Sell
-1,063
Closed -$43K 92
2019
Q1
$43K Buy
+1,063
New +$42.6K 0.03% 59

Other funds holding PFE

New World Advisors's PFE Position: Q1 2022 in Review

New World Advisors sold out of Pfizer (PFE) in Q1 2022, closing a stake of 3,959 shares — an estimated $234K sold.

New World Advisors first reported a position in PFE in Q1 2019 and held it in 4 quarters. The position peaked at $828K in Q2 2021. 3,195 funds tracked by Wall St. Rank hold PFE as of Q1 2022.

  • New World Advisors reported no remaining Pfizer position as of Q1 2022 after selling out during the quarter.
  • New World Advisors sold 3,959 Pfizer shares in Q1 2022, an estimated $234K.
  • New World Advisors first reported a position in Pfizer in Q1 2019 and held it in 4 quarters.
  • New World Advisors's Pfizer position peaked at $828K in Q2 2021.
  • 3,195 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.

Based on New World Advisors's 13F filing for Q1 2022, filed 11 May 2022.